Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Malibu Boats | MBUU | Apr 17, 2025 | 27.01 | +3.45 |
Mamas Creations | MAMA | Apr 17, 2025 | 6.53 | +3.49 |
Mammoth Energy Services | TUSK | Apr 17, 2025 | 2.63 | -1.13 |
Manchester United A | MANU | Apr 17, 2025 | 13.90 | +0.72 |
Mangoceuticals | MGRX | Apr 17, 2025 | 2.57 | +22.38 |
Manhattan Associates | MANH | Apr 17, 2025 | 163.57 | +1.54 |
Manhattan Bridge Capital | LOAN | Apr 17, 2025 | 5.39 | +1.70 |
Manitowoc | MTW | Apr 17, 2025 | 7.59 | +1.47 |
Mannatech | MTEX | Apr 17, 2025 | 9.50 | 0.00 |
MannKind | MNKD | Apr 17, 2025 | 4.54 | +0.22 |
ManpowerGroup | MAN | Apr 17, 2025 | 40.07 | -19.07 |
Manulife Financial | MFC | Apr 17, 2025 | 28.61 | +0.07 |
Maplebear | CART | Apr 17, 2025 | 42.99 | +2.16 |
Marathon Digital | MARA | Apr 17, 2025 | 12.66 | +2.76 |
Marathon Petroleum | MPC | Apr 17, 2025 | 127.72 | +2.94 |
Maravai LifeSciences A | MRVI | Apr 17, 2025 | 1.77 | +2.91 |
Marblegate Acquisition A | GATE | Apr 17, 2025 | 36.05 | 0.00 |
Marchex B | MCHX | Apr 17, 2025 | 1.47 | +5.76 |
Marcus | MCS | Apr 17, 2025 | 16.20 | +1.25 |
Marcus & Millichap | MMI | Apr 17, 2025 | 31.25 | +1.49 |
Marex Group | MRX | Apr 17, 2025 | 38.61 | +1.31 |
Marin Software | MRIN | Apr 17, 2025 | 0.50 | -5.76 |
Marine Petroleum Trust U | MARPS | Apr 17, 2025 | 3.90 | -0.51 |
Marine Products | MPX | Apr 17, 2025 | 8.26 | +2.23 |
MarineMax | HZO | Apr 17, 2025 | 18.80 | +3.98 |
Maris-Tech | MTEK | Apr 17, 2025 | 1.87 | -6.18 |
Markel | MKL | Apr 17, 2025 | 1 768.53 | +0.30 |
Marker Therapeutics | MRKR | Apr 17, 2025 | 1.15 | +6.48 |
Market Vectors Bdc Income ETF | BIZD | Apr 17, 2025 | 15.06 | +1.83 |
Market Vectors Investment Grade | FLTR | Apr 17, 2025 | 25.32 | +0.20 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.